WMSA
HZNP

Weiss Multi-Strategy Advisers’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-45,300
Closed -$5.16M – 795
2022
Q4 		$5.16M Buy
+45,300
New +$3.76M 0.15% 216

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Weiss Multi-Strategy Advisers's HZNP Position: Q3 2023 in Review

Weiss Multi-Strategy Advisers sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 126,117 shares — an estimated $13M sold.

Weiss Multi-Strategy Advisers first reported a position in HZNP in Q2 2019 and held it in 17 quarters. The position peaked at $15.2M in Q4 2022. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 126,117 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $13M.
  • Weiss Multi-Strategy Advisers first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019 and held it in 17 quarters.
  • Weiss Multi-Strategy Advisers's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $15.2M in Q4 2022.
  • 485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.